Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia ; volume:10 ; number:1 ; year:2018 ; pages:91-106 ; extent:16
EMBO molecular medicine / European Molecular Biology Organization ; 10, Heft 1 (2018), 91-106 (gesamt 16)

Creator: Zanardi, Alan
Conti, Antonio
Cremonesi, Marco
D'Adamo, Patrizia
Gilberti, Enrica
Apostoli, Pietro
Cannistraci, Carlo Vittorio
Piperno, Alberto
David, Samuel
Alessio, Massimo

DOI: 10.15252/emmm.201708361

URN: urn:nbn:de:101:1-2022083007520598317014

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zanardi, Alan
Conti, Antonio
Cremonesi, Marco
D'Adamo, Patrizia
Gilberti, Enrica
Apostoli, Pietro
Cannistraci, Carlo Vittorio
Piperno, Alberto
David, Samuel
Alessio, Massimo

Other Objects (12)

Preclinical studies of transcranial photobiomodulation in the neurological diseases

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

Omi inhibition ameliorates neuron apoptosis and neurological deficit after subarachnoid hemorrhage in rats

Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice

Neurological update: non-motor symptoms in atypical parkinsonian syndromes

Long COVID-19: Objectifying most self-reported neurological symptoms

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond

Life style and Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article

Variation of Functional Neurological Symptoms and Emotion Regulation with Time

Application of metagenomics for diagnosis of broilers displaying neurological symptoms

Preclinical studies of transcranial photobiomodulation in the neurological diseases

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

Omi inhibition ameliorates neuron apoptosis and neurological deficit after subarachnoid hemorrhage in rats

Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice

Neurological update: non-motor symptoms in atypical parkinsonian syndromes

Long COVID-19: Objectifying most self-reported neurological symptoms

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond

Life style and Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article

Variation of Functional Neurological Symptoms and Emotion Regulation with Time

Application of metagenomics for diagnosis of broilers displaying neurological symptoms

Preclinical studies of transcranial photobiomodulation in the neurological diseases

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

Omi inhibition ameliorates neuron apoptosis and neurological deficit after subarachnoid hemorrhage in rats

Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice

Neurological update: non-motor symptoms in atypical parkinsonian syndromes

Long COVID-19: Objectifying most self-reported neurological symptoms

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond

Life style and Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article

Variation of Functional Neurological Symptoms and Emotion Regulation with Time

Application of metagenomics for diagnosis of broilers displaying neurological symptoms

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Preclinical studies of transcranial photobiomodulation in the neurological diseases

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

Omi inhibition ameliorates neuron apoptosis and neurological deficit after subarachnoid hemorrhage in rats

Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice

Neurological update: non-motor symptoms in atypical parkinsonian syndromes

Long COVID-19: Objectifying most self-reported neurological symptoms

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond

Life style and Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article

Variation of Functional Neurological Symptoms and Emotion Regulation with Time

Application of metagenomics for diagnosis of broilers displaying neurological symptoms

Preclinical studies of transcranial photobiomodulation in the neurological diseases

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

Omi inhibition ameliorates neuron apoptosis and neurological deficit after subarachnoid hemorrhage in rats

Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice

Neurological update: non-motor symptoms in atypical parkinsonian syndromes

Long COVID-19: Objectifying most self-reported neurological symptoms

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond

Life style and Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article

Variation of Functional Neurological Symptoms and Emotion Regulation with Time

Application of metagenomics for diagnosis of broilers displaying neurological symptoms

Preclinical studies of transcranial photobiomodulation in the neurological diseases

Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models

Omi inhibition ameliorates neuron apoptosis and neurological deficit after subarachnoid hemorrhage in rats

Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Systemic administration of heparin ameliorates radiation-induced oral mucositis—preclinical studies in mice

Neurological update: non-motor symptoms in atypical parkinsonian syndromes

Long COVID-19: Objectifying most self-reported neurological symptoms

Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond

Life style and Parkinson’s disease : Neurology and Preclinical Neurological Studies - Review Article

Variation of Functional Neurological Symptoms and Emotion Regulation with Time

Application of metagenomics for diagnosis of broilers displaying neurological symptoms

Related objects

Reset password